PRESENTATION
Q1 2022 — Earnings presentation
Q1 2022PDF · 24 pages2.5 MB
Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer 2022 First Quarter Earnings John Banovetz Executive Vice President, Chief Technology Officer & Environmental Responsibility (unaudited) Bruce Jermeland Senior Vice President, Investor Relations -- 1 of 24 -- 2 2022 Q1 Earnings – April 26, 2022. All rights reserved. Forward looking statement This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2021, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy (including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruption or supply chain interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this presentation is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this presentation as a result of new information or future events or developments. This presentation refers to certain non-GAAP financial measures. Refer to 3M’s April 26, 2022, press release for descriptions of non-GAAP financial measures such as free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release. Note on non-GAAP financial measures -- 2 of 24 -- 3 2022 Q1 Earnings – April 26, 2022. All rights reserved. Change to non-GAAP measures - special items • Expanding current scope of non-GAAP measure adjustments for special items to include all impacts of accrual changes and legal fees for respirator mask, PFAS and Combat Arms matters – Increases transparency of our financial reporting and understanding of underlying business performance – Issued Form 8-K with updated history for the past three years reflecting this change, and updated full-year guidance on this basis in this morning’s earnings press release $M, except EPS GAAP amounts comparable to non-GAAP amounts mentioned below 2021 2020 2019 Operating income $7,369 $7,161 $6,174 Operating margin 20.8% 22.3% 19.2% EPS $10.12 $9.36 $7.72 Certain amounts adjusted for special items (non-GAAP measures)* Previous basis for special items: Operating income $7,369 $6,844 $6,822 Operating margin 20.8% 21.3% 21.2% EPS $10.12 $8.85 $8.79 Updated basis for special items: Operating income $7,832 $7,180 $6,911 Operating margin 22.2% 22.3% 21.5% EBITDA margin 27.6% 28.2% 26.5% EPS $10.73 $9.29 $8.90 Memo: Impact of change on previous basis operating margin 1.4% 1.0% 0.3% Additional net costs per share treated as special item under updated basis $0.61 $0.44 $0.11 *See 2021 Annual Report on Form 10-K and Form 8-K dated April 26, 2022 for information regarding these non-GAAP measures on the previous basis and updated basis, respectively. -- 3 of 24 -- 4 2022 Q1 Earnings – April 26, 2022. All rights reserved. Change to non-GAAP measures - special items Q1 2022 Q4 2021 Q1 2021 GAAP EPS $2.26 $2.31 $2.77 Special items: Net costs for significant litigation: Zwijndrecht-related (PFAS-related environmental commitments as previously announced on March 30, 2022) 0.26 — — Other significant litigation 0.13 0.14 0.18 Total 0.39 0.14 0.18 Adjusted EPS $2.65 $2.45 $2.95 Memo: Adjusted operating margin 21.4% 20.0% 24.1% • Expanding current scope of non-GAAP measure adjustments for special items to include all impacts of accrual changes and legal fees for respirator mask, PFAS and Combat Arms matters – Increases transparency of our financial reporting and understanding of underlying business performance – Issued Form 8-K with updated history for the past three years reflecting this change, and updated full-year guidance on this basis in this morning’s earnings press release -- 4 of 24 -- 5 2022 Q1 Earnings – April 26, 2022. All rights reserved. 1 2 3 4 5 Growing faster than the markets and economies we serve Expanding margins and EPS through operating rigor, productivity, and price Delivering robust cash flow through supply chain recovery and improvements in working capital Investing capital in high growth, high return portfolios that utilize our fundamental strengths Advancing sustainability commitments to reduce GHG emissions and improve water quality Maintaining a strong balance sheet, providing flexibility for M&A and shareholder returns 6 Delivering growth and shareholder value in 2022 -- 5 of 24 -- 6 Creating value and delivering for customers • Delivered solid growth and sequential improvement in operating margins while investing for long-term growth in sizable, significant markets • Focused on customers while managing supply chain, inflation, and geopolitical pressures – Prioritizing serving our customers while managing supply chain pressures – Driving price to offset inflationary pressures – Managing impact of Russia/Ukraine conflict • Optimizing portfolio to create value for customers and shareholders – Food Safety divestiture: on track to close by end of Q3 – Acquired the technology assets of LeanTec to advance digital solutions for auto body shop customers • Returned $1.6B of cash to shareholders, 64 straight years of annual dividend increases • Proactively managing litigation; filed first Combat Arms appeals • Following through on sustainability commitments • FY 2022 outlook: grow above macro and improve operational performance Organic growth +1.7% Includes (0.5%) impact from disposable respirator decline Adjusted operating margin 21.4% Adjusted earnings per share $2.65 Q1 2022 -- 6 of 24 -- 7 2022 Q1 Earnings – April 26, 2022. All rights reserved. Executing on our environmental stewardship goals 2002 2015 2023 2025 2030 2040 2050 GHG emissions reported by WRI/WBCSD GHG Protocol 69.2% Scope 1 and 2 emission reduction (2002-2015) 39.8% water reduction (2005-2015, indexed) Complete installation of water quality systems at largest locations 20% water reduction, indexed 125 million pounds virgin fossil-based plastic 25% water reduction, indexed 50% Scope 1 and 2 emission reduction 80% Scope 1 and 2 emission reduction Carbon neutrality, Scope 1 and 2 emissions 2021 2005 Reset GHG and water baselines to 2019 26.1% Scope 1 and 2 emission reduction 10.7% water reduction, indexed Launch of Global Impact Report – May 11, 2022 35.5% Scope 1 and 2 emission reduction (2002-2005) What we said: 2021 announced $1 billion environmental investment • 10% water reduction by 2022 moving toward 25% water reduction by 2030, indexed • Improve water quality through installation of purification technologies at largest water-using locations by 2023 and fully operational by 2024 • Reduce Scope 1 and 2 emissions 50% by 2030 and carbon neutrality in our operations by 2050 • Reduce dependence on virgin fossil-based plastic by 125 million pounds by 2025 Where we are: 2021 progress • Reduced water usage nearly 11%, indexed • Installed state-of-the-art water quality system in Zwijndrecht; pilot work completed in Decatur, AL; Cordova, IL; and Cottage Grove, MN • Reduced Scope 1 & 2 emissions over 26% • Reduced over 18 million pounds virgin-based plastic use Where we’re going: 2022 expectations • Over 5% additional water reduction • Complete installation and operation of systems to further improve water quality in Cordova IL; expansion of water quality capabilities in Zwijndrecht, Cottage Grove, MN and Decatur, AL • Bending the curve on carbon emissions, surpassing 50% renewable electricity two years ahead of plan • Doubling the reduction of virgin-based plastic use -- 7 of 24 -- 8 2022 Q1 Earnings – April 26, 2022. All rights reserved. Financial details of the quarter -- 8 of 24 -- 9 2022 Q1 Earnings – April 26, 2022. All rights reserved. Q1 2022 operating margin and EPS +9.0% Adjusted operating margin Adjusted earnings per share Commentary Q1 2021 24.1% $2.95 Total organic growth/ productivity/other -0.4% $— Disposable respirator -0.1% -$0.03 • YoY disposable respirator decline in demand Remaining organic growth/ productivity/other -0.3% +$0.03 • Strong pricing, spending discipline and benefits from restructuring actions • Manufacturing headwinds from global supply chain challenges, including geopolitical impacts • Increased investments in growth, productivity and sustainability Raw material -2.4% -$0.30 • Raw material and logistics cost inflation FX +0.1% -$0.04 • Net of hedge impact Other expense/income NA +$0.01 • Primarily non-operating pension expense offset by lower net interest expense Adjusted tax rate* NA -$0.02 • Q1 2022 adjusted tax rate of 17.6% versus 16.9% in Q1 2021 Shares outstanding NA +$0.05 • Average diluted shares down 2% Q1 2022 21.4% $2.65 * The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above. -- 9 of 24 -- 10 2022 Q1 Earnings – April 26, 2022. All rights reserved. Q1 2022 cash flow and balance sheet Adjusted free cash flow • Q1: $0.7B, down 50% YoY Adjusted free cash flow conversion • Continue to expect full-year free cash flow conversion in the range of 90% to 100% • Q1: 47% (in-line with expectations), down 36 ppts YoY • Q1 YoY decline due to higher cash compensation and increase in capex for growth and sustainability investments Capital expenditures • Q1: $424M, up 37% YoY • Continue to expect full-year capex in the range of $1.7B to $2.0B Net debt • Q1: $13.3B, up 2% YoY Cash returned to shareholders • Q1: dividends $852M; share repurchases $773M • Expect full-year share repurchases of ~$2B Adjusted free cash flow $0.7B -50% year-on-year Adjusted free cash flow conversion 47% -36 ppts year-on-year Cash returned to shareholders $1.6B +49% year-on-year -- 10 of 24 -- 11 2022 Q1 Earnings – April 26, 2022. All rights reserved. Safety & Industrial Transportation & Electronics Health Care Consumer Business Group performance -- 11 of 24 -- 12 2022 Q1 Earnings – April 26, 2022. All rights reserved. Organic growth 0.5% Includes (1.5%) impact from disposable respirator decline Adjusted operating margin 22.9% Q1 2022 commentary Safety & Industrial • Mid-single digit organic growth in industrial adhesives and tapes, electrical markets, abrasives, and closure and masking systems, while personal safety declined • Disposable respirator sales declined nearly $50M, or 8% organically YoY; reduced segment organic growth by 1.5 ppts • Adjusted operating margins -3.5 ppts YoY; impacted by increased raw materials/logistics costs and manufacturing productivity headwinds; partially offset by selling price actions, strong spending discipline and restructuring benefits Long-term trends Industrial activity Digitization Sustainability Use of robotics & automation Key investment priorities Personal safety Connected solutions Sustainable products -- 12 of 24 -- 13 2022 Q1 Earnings – April 26, 2022. All rights reserved. Transportation & Electronics • Organic growth led by commercial solutions; automotive flat while electronics and transportation safety declined • Semiconductor supply chain challenges continue impacting global auto builds (Q1: -5% YoY, IHS) and electronics end-markets • Operating margins -2.0 ppts YoY; impacted by increased raw materials/logistics costs, manufacturing productivity headwinds, and investments in auto electrification; partially offset by selling price actions, strong spending discipline and restructuring benefits • Q2 forecasts: IHS auto builds up ~2% YoY and down ~(3)% sequentially; smartphones up ~1% YoY and down ~(5)% sequentially Q1 2022 commentary Organic growth -0.3% Operating margin 21.2% Key investment priorities Auto electrification/mobility Semiconductor Electronic materials Graphic and architectural films Long-term trends Auto electrification Fab manufacturing Factory automation Data center solutions -- 13 of 24 -- 14 2022 Q1 Earnings – April 26, 2022. All rights reserved. Q1 2022 commentary • Organic growth across all divisions led by food safety, separation and purification sciences, medical solutions and health information systems • COVID-19 (Omicron) continues to impact U.S. elective procedure volumes (Q1: healthcare 85-90%; oral care 85-90% vs pre-COVID) • Operating margins -1.4 ppts YoY; impacted by increased raw materials/logistics costs, manufacturing productivity headwinds, and investments; partially offset by sales growth (including selling price actions), strong spending discipline and restructuring benefits • U.S. healthcare elective procedure and oral care volumes expected to improve in Q2 to 90-95% of pre-COVID levels Health Care Organic growth 4.7% Operating margin 21.1% Long-term trends Aging population Health access Shift to lowest-cost settings Digital & connected solutions Key investment priorities Wound care Healthcare IT Biopharma filtration -- 14 of 24 -- 15 2022 Q1 Earnings – April 26, 2022. All rights reserved. Organic growth 3.4% Operating margin 17.1% Consumer Q1 2022 commentary • Organic growth across all divisions led by consumer health and safety and continued demand for home care, stationery and office and home improvement products • Operating margins -3.7 ppts YoY; impacted by increased raw materials/logistics and outsourced hardgoods manufacturing costs, and manufacturing productivity headwinds; partially offset by sales growth (including selling price actions), strong spending discipline, and restructuring benefits Key investment priorities Home improvement Package protection & shipping Consumer safety & well-being Appearance auto care Long-term trends Increased time spent at home E-commerce/digital/data analytics Heightened focus on well-being Sustainability -- 15 of 24 -- 16 2022 Q1 Earnings – April 26, 2022. All rights reserved. 2022 outlook -- 16 of 24 -- 17 2022 Q1 Earnings – April 26, 2022. All rights reserved. Note: Above guidance does not reflect the impact of pending divestiture of Food Safety business via Reverse Morris Trust (RMT) transaction with Neogen Organic growth 2% to 5% Adjusted earnings per share $10.75 to $11.25 Free cash flow conversion 90% to 100% 2022 planning estimates – updated to reflect change in reporting Current trend Macro environment • IPI & GDP softening to ~3% • Monitoring Omicron subvariant impacts in China • Geopolitical uncertainty due to Russia/Ukraine conflict • Increasing FX volatility End-markets • Most end-markets are strong; however, auto OEM build (CY +4% YoY) and smartphone (CY +2% YoY) forecasts moderating due to continued semiconductor and supply chain challenges along with geopolitical impacts • Industry projections for U.S. healthcare elective procedure volumes at ~95% to 100% by year-end, impacted by COVID-19 driven staff shortages and patient cancellations Supply chain constraints • Supply chain challenges worsening due to geopolitical risks Raw materials & logistics pressure • Raw material & logistics inflation driving incremental pressure • Selling price expected to offset raw material & logistics inflation Original outlook Macro environment • IPI & GDP of ~4% • Uneven economic recovery due to COVID-19 variants and vaccination rates End-markets • End-markets expected to be strong; growth in automotive (CY+9% YoY) and electronics (CY +4% YoY) as semiconductor chips supply progresses • Industry projections for U.S. healthcare elective procedure volumes at ~100% by year-end Supply chain constraints • Global supply chain challenges expected to remain at least through 1H 2022 Raw materials & logistics pressure • Raw material & logistics estimated headwind of $350M to $450M YoY • Selling price expected to offset raw material & logistics inflation -- 17 of 24 -- 18 2022 Q1 Earnings – April 26, 2022. All rights reserved. Q&A Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer John Banovetz Executive Vice President, Chief Technology Officer & Environmental Responsibility Bruce Jermeland Senior Vice President, Investor Relations -- 18 of 24 -- 19 2022 Q1 Earnings – April 26, 2022. All rights reserved. Appendix -- 19 of 24 -- 20 2022 Q1 Earnings – April 26, 2022. All rights reserved. Q1 2022 P&L ($M) Q1 2022 Q1 2021 Change Sales $8,829 $8,851 -0.3% Gross profit $4,003 $4,326 -7.5% % to sales 45.3% 48.9% -3.6 pts SG&A $1,882 $1,808 +4.0% % to sales 21.3% 20.5% +0.8 pts R&D & related $480 $524 -8.4% % to sales 5.4% 5.9% -0.5 pts Operating income $1,641 $1,994 -17.7% % to sales 18.6% 22.5% -3.9 pts Net income $1,299 $1,624 -20.0% GAAP earnings per share $2.26 $2.77 -18.4% -- 20 of 24 -- 21 2022 Q1 Earnings – April 26, 2022. All rights reserved. Q1 2022 sales recap Americas EMEA APAC Worldwide Organic growth +2.5% -1.9% +2.7% +1.7% Acquisitions/divestitures —% —% —% —% FX —% -5.7% -2.7% -2.0% Total growth +2.5% -7.6% —% -0.3% U.S. Canada Mexico Brazil China/HK Japan Organic growth +1% +22% +10% +14% -3% +3% -- 21 of 24 -- 22 2022 Q1 Earnings – April 26, 2022. All rights reserved. Business segment information ($M) Net Sales Q1 2022 Sales Growth Adjusted Operating Income* Adjusted Operating Margin* Business groups Q1 2022 Q1 2021 Organic growth FX M&A Total Sales Change Q1 2022 Q1 2021 Percent change Q1 2022 Q1 2021 Safety & Industrial $3,051 $3,099 0.5% -2.1% —% -1.6% $699 $817 -14.4% 22.9% 26.4% Transportation & Electronics $2,340 $2,396 -0.3% -2.0% —% -2.3% $496 $556 -10.6% 21.2% 23.2% Health Care $2,124 $2,069 4.7% -2.0% —% 2.7% $448 $464 -3.5% 21.1% 22.5% Consumer $1,313 $1,289 3.4% -1.6% —% 1.8% $224 $269 -16.6% 17.1% 20.8% Total Operating Business Segment $1,867 $2,106 Corporate & Unallocated $1 $(2) $24 $23 Total $8,829 $8,851 1.7% -2.0% —% -0.3% $1,891 $2,129 -11.2% 21.4% 24.1% *"Safety & Industrial", "Corporate & Unallocated", "Total Operating Business Segment" and "Total" provided on an adjusted basis Organic growth = organic volume + price -- 22 of 24 -- 23 2022 Q1 Earnings – April 26, 2022. All rights reserved. ($M) Net Sales Business groups Q1 2022 Q1 2021 Abrasives 329 323 Automotive Aftermarket 295 294 Closure and Masking Systems 258 243 Electrical Materials 309 301 Industrial Adhesives & Tapes 621 598 Personal Safety 1,127 1,229 Roofing Granules 112 108 Other Safety & Industrial — 3 Total Safety & Industrial Business Group 3,051 3,099 Advanced Materials 305 315 Automotive & Aerospace 460 488 Commercial Solutions 454 427 Electronics 923 951 Transportation Safety 198 215 Other Transportation & Electronics — — Total Transportation & Electronics Business Group 2,340 2,396 ($M) Net Sales Business groups Q1 2022 Q1 2021 Food Safety 92 87 Health Information Systems 300 289 Medical Solutions 1,128 1,093 Oral Care 354 360 Separation & Purification Sciences 250 240 Other Health Care — — Total Health Care Business Group 2,124 2,069 Consumer Health & Safety 161 144 Home Care 274 272 Home Improvement 609 604 Stationery & Office 269 268 Other Consumer — 1 Total Consumer Business Group 1,313 1,289 Corporate & Unallocated 1 (2) Total 3M 8,829 8,851 Additional sales detail -- 23 of 24 -- -- 24 of 24 --